What is Abbott's SG&A?

Abbott (ABT) reported SG&A of $3.74B in Q1 2026.

How has Abbott's SG&A changed year-over-year?

Abbott's SG&A increased by 22.2% year-over-year, from $3.06B to $3.74B.

What is the long-term trend for Abbott's SG&A?

Over 4 years (2021 to 2025), Abbott's SG&A has grown at a 2.2% compound annual growth rate (CAGR), from $11.32B to $12.33B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Abbott ABT SG&A

SG&A at other companies

Becton, Dickinson and CompanyBDX

$1.21B+8.6%

Bio-Rad LaboratoriesBIO

$212.4M+1.7%

Johnson & JohnsonJNJ

$6.03B+18.0%

HaemoneticsHAE

$120.93M+5.0%

Merit Medical SystemsMMSI

$118.21M+10.0%

Boston ScientificBSX

$1.78B+11.5%

Segments

By segment

See full

Medical Devices$1.39B+7.8%

Nutritional Products$563M-2.3%

Diagnostic Products$448M+14.3%

Established Pharmaceuticals$376M+7.1%

Other financials

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation

See full

Market cap$162.41B-29.8%

Enterprise value$189.65B-20.3%

P/E25.9×+8.7×

P/S3.6×-1.9×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's SG&A?: Abbott (ABT) reported SG&A of $3.74B in Q1 2026.
How has Abbott's SG&A changed year-over-year?: Abbott's SG&A increased by 22.2% year-over-year, from $3.06B to $3.74B.
What is the long-term trend for Abbott's SG&A?: Over 4 years (2021 to 2025), Abbott's SG&A has grown at a 2.2% compound annual growth rate (CAGR), from $11.32B to $12.33B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.